Annual Accounts Payable
$772.00 K
-$2.87 M-78.79%
31 December 2023
Summary:
Protagonist Therapeutics annual accounts payable is currently $772.00 thousand, with the most recent change of -$2.87 million (-78.79%) on 31 December 2023. During the last 3 years, it has fallen by -$828.00 thousand (-51.75%). PTGX annual accounts payable is now -86.48% below its all-time high of $5.71 million, reached on 31 December 2018.PTGX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.05 M
-$580.00 K-15.98%
30 September 2024
Summary:
Protagonist Therapeutics quarterly accounts payable is currently $3.05 million, with the most recent change of -$580.00 thousand (-15.98%) on 30 September 2024. Over the past year, it has increased by +$2.28 million (+294.95%). PTGX quarterly accounts payable is now -61.43% below its all-time high of $7.91 million, reached on 30 June 2021.PTGX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +294.9% |
| 3 y3 years | -51.8% | +90.6% |
| 5 y5 years | -72.3% | +9.3% |
PTGX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.8% | at low | -57.4% | +294.9% |
| 5 y | 5 years | -78.8% | at low | -61.4% | +331.9% |
| alltime | all time | -86.5% | +121.2% | -61.4% | +331.9% |
Protagonist Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.05 M(-16.0%) |
| June 2024 | - | $3.63 M(+3.5%) |
| Mar 2024 | - | $3.51 M(+354.3%) |
| Dec 2023 | $772.00 K(-78.8%) | $772.00 K(-38.3%) |
| Sept 2023 | - | $1.25 M(-72.6%) |
| June 2023 | - | $4.57 M(+13.7%) |
| Mar 2023 | - | $4.02 M(+10.5%) |
| Dec 2022 | $3.64 M(+127.5%) | $3.64 M(-22.8%) |
| Sept 2022 | - | $4.71 M(+233.9%) |
| June 2022 | - | $1.41 M(-80.3%) |
| Mar 2022 | - | $7.16 M(+347.4%) |
| Dec 2021 | $1.60 M(-48.0%) | $1.60 M(+126.6%) |
| Sept 2021 | - | $706.00 K(-91.1%) |
| June 2021 | - | $7.91 M(+189.3%) |
| Mar 2021 | - | $2.73 M(-11.2%) |
| Dec 2020 | $3.08 M | $3.08 M(+9.9%) |
| Sept 2020 | - | $2.80 M(-2.0%) |
| June 2020 | - | $2.85 M(-22.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.70 M(+32.8%) |
| Dec 2019 | $2.79 M(-51.1%) | $2.79 M(+76.2%) |
| Sept 2019 | - | $1.58 M(-43.2%) |
| June 2019 | - | $2.79 M(-56.8%) |
| Mar 2019 | - | $6.45 M(+13.0%) |
| Dec 2018 | $5.71 M(+354.3%) | $5.71 M(+17.2%) |
| Sept 2018 | - | $4.87 M(+113.8%) |
| June 2018 | - | $2.28 M(+74.3%) |
| Mar 2018 | - | $1.31 M(+4.0%) |
| Dec 2017 | $1.26 M(+8.1%) | $1.26 M(-44.6%) |
| Sept 2017 | - | $2.27 M(-14.1%) |
| June 2017 | - | $2.64 M(+133.1%) |
| Mar 2017 | - | $1.13 M(-2.7%) |
| Dec 2016 | $1.16 M(-6.7%) | $1.16 M(-50.2%) |
| Sept 2016 | - | $2.33 M(+62.0%) |
| June 2016 | - | $1.44 M(-23.8%) |
| Mar 2016 | - | $1.89 M(+51.6%) |
| Dec 2015 | $1.25 M(+257.3%) | $1.25 M |
| Dec 2014 | $349.00 K | - |
FAQ
- What is Protagonist Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly accounts payable year-on-year change?
What is Protagonist Therapeutics annual accounts payable?
The current annual accounts payable of PTGX is $772.00 K
What is the all time high annual accounts payable for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual accounts payable is $5.71 M
What is Protagonist Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PTGX is $3.05 M
What is the all time high quarterly accounts payable for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly accounts payable is $7.91 M
What is Protagonist Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PTGX quarterly accounts payable has changed by +$2.28 M (+294.95%)